Related Experiment Video
Updated: May 1, 2026

Peptide-based Identification of Functional Motifs and their Binding Partners
Published on: June 30, 2013
Associations between HIV infection and subclinical coronary atherosclerosis
Insights
HIV-infected men show increased coronary artery plaque, particularly noncalcified types, compared to uninfected men. This finding highlights a higher prevalence of coronary atherosclerosis in individuals with HIV, independent of traditional risk factors.
Area of Science:
- Cardiology
- Infectious Diseases
- Public Health
Background:
- Coronary artery disease (CAD) association with HIV infection requires further clarification.
- HIV-infected individuals may face elevated cardiovascular risks.
Purpose of the Study:
- To investigate whether HIV-infected men exhibit greater coronary atherosclerosis than their uninfected counterparts.
- To assess the prevalence and extent of coronary plaque in HIV-infected versus uninfected men.
Main Methods:
- Cross-sectional study within the Multicenter AIDS Cohort Study.
- Inclusion of 618 HIV-infected and 383 uninfected men (aged 40-70) without prior coronary revascularization.
- Assessment of coronary artery calcium (CAC), plaque presence/type, and stenosis using cardiac computed tomography (CT) and CT angiography.
Main Results:
- HIV-infected men had higher prevalence of CAC (PR 1.21) and any plaque (PR 1.14), including noncalcified (PR 1.28) and mixed plaque (PR 1.35).
- These associations persisted after adjusting for traditional CAD risk factors.
- HIV-infected men also showed a greater extent of noncalcified plaque and higher prevalence of >50% coronary stenosis (PR 1.48), though the latter was not significant after risk factor adjustment.
Conclusions:
- Coronary artery plaque, especially noncalcified plaque, is more prevalent and extensive in HIV-infected men.
- Findings are independent of traditional cardiovascular disease risk factors.
- Study limitations include cross-sectional design and male-only participants.
Background:
Coronary artery disease (CAD) has been associated with HIV infection, but data are not consistent.
Objective:
To determine whether HIV-infected men have more coronary atherosclerosis than uninfected men.
Design:
Cross-sectional study.
Setting:
Multicenter AIDS Cohort Study.
Participants:
HIV-infected (n = 618) and uninfected (n = 383) men who have sex with men who were aged 40 to 70 years, weighed less than 136 kg (200 lb), and had no history of coronary revascularization.
Measurements:
Presence and extent of coronary artery calcium (CAC) on noncontrast cardiac computed tomography (CT) and of any plaque; noncalcified, mixed, or calcified plaque; or stenosis on coronary CT angiography.
Results:
1001 men had noncontrast CT, of whom 759 had coronary CT angiography. After adjustment for age, race, CT scanning center, and cohort, HIV-infected men had a greater prevalence of CAC (prevalence ratio [PR], 1.21 [95% CI, 1.08 to 1.35]; P = 0.001) and any plaque (PR, 1.14 [CI, 1.05 to 1.24]; P = 0.001), including noncalcified (PR, 1.28 [CI, 1.13 to 1.45]; P < 0.001) and mixed (PR, 1.35 [CI, 1.10 to 1.65]; P = 0.004) plaque, than uninfected men. Associations between HIV infection and any plaque or noncalcified plaque remained significant (P < 0.005) after CAD risk factor adjustment. HIV-infected men had a greater extent of noncalcified plaque after CAD risk factor adjustment (P = 0.026). They also had a greater prevalence of coronary artery stenosis greater than 50% (PR, 1.48 [CI, 1.06 to 2.07]; P = 0.020), but not after CAD risk factor adjustment. Longer duration of highly active antiretroviral therapy (PR, 1.09 [CI, 1.02 to 1.17]; P = 0.007) and lower nadir CD4+ T-cell count (PR, 0.80 [CI, 0.69 to 0.94]; P = 0.005) were associated with coronary stenosis greater than 50%.
Limitation:
Cross-sectional observational study design and inclusion of only men.
Conclusion:
Coronary artery plaque, especially noncalcified plaque, is more prevalent and extensive in HIV-infected men, independent of CAD risk factors.
Primary Funding Source:
National Heart, Lung, and Blood Institute and National Institute of Allergy and Infectious Diseases.
Related Concept Videos
Coronary Artery Disease III: Clinical Manifestations
Coronary Artery Disease I: Introduction
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Acute Coronary Syndrome III: Diagnostic Studies
Coronary Artery Disease II: Pathophysiology
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

